Literature DB >> 8374370

Aspirin and colorectal cancer.

A Paganini-Hill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374370      PMCID: PMC1678580          DOI: 10.1136/bmj.307.6899.278

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Aspirin use and reduced risk of fatal colon cancer.

Authors:  A Paganini-Hill; G Hsu; R K Ross; B E Henderson
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

2.  Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; L F Watson
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

Review 3.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  A K Verma; C L Ashendel; R K Boutwell
Journal:  Cancer Res       Date:  1980-02       Impact factor: 12.701

5.  Aspirin use and chronic diseases: a cohort study of the elderly.

Authors:  A Paganini-Hill; A Chao; R K Ross; B E Henderson
Journal:  BMJ       Date:  1989-11-18

6.  16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin.

Authors:  F R DeRubertis; P A Craven; R Saito
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

7.  Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients.

Authors:  T Han; T Nemoto; E J Ledesma; S Bruno
Journal:  Int J Immunopharmacol       Date:  1983

8.  Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

Authors:  R F Logan; J Little; P G Hawtin; J D Hardcastle
Journal:  BMJ       Date:  1993-07-31

9.  Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin.

Authors:  T Narisawa; P Hermanek; M Habs; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
View more
  4 in total

Review 1.  Aspirin, NSAIDs, and digestive tract cancers.

Authors:  M J Thun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

2.  Therapeutic potential of aspirin in cancer of the colon.

Authors:  G P Morgan; J G Williams
Journal:  BMJ       Date:  1993-10-16

Review 3.  Associations between physical activity and susceptibility to cancer: possible mechanisms.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1998-11       Impact factor: 11.136

4.  Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia.

Authors:  I I Peleg; M F Lubin; G A Cotsonis; W S Clark; C M Wilcox
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.